Skip to main content
Clinical Trials/NCT04080349
NCT04080349
Unknown
Phase 4

Comparison of Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women Delivered Only by Cesarean Delivery:a Randomized Controlled Trial

Cairo University0 sites300 target enrollmentSeptember 10, 2019

Overview

Phase
Phase 4
Intervention
Dinoprostone 3 mg
Conditions
IUD Pain
Sponsor
Cairo University
Enrollment
300
Primary Endpoint
The difference in pain scores during intrauterine device insertion
Last Updated
6 years ago

Overview

Brief Summary

To compare the effect of vaginal dinoprostone versus vaginal misoprostol administered before the copper intrauterine device(IUD) insertion in reducing IUD insertion pain and the difficulty in inserting the IUD in women delivered only by cesarean section.

Detailed Description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.

Registry
clinicaltrials.gov
Start Date
September 10, 2019
End Date
December 5, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Samy aly ashour

assistant professor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • women delivered only by elective cesarean section and not received analgesics in the last 24 hours

Exclusion Criteria

  • contraindications to dinoprostone or misoprostol or IUD insertion and allergy to study drugs.

Arms & Interventions

dinoprostone

1 vaginal tablet of dinoprostone (3mg) (prostin® E2, Pharmacia \& Upjohn, Puurs, Belgium) inserted by the study nurse 3 hours before IUD insertion.

Intervention: Dinoprostone 3 mg

misoprostol

1 vaginal tablet of misoprostol (200 mcg) (Misotac®; Sigma Pharma, SAE, Egypt) inserted by the study nurse 3 hours before IUD insertion.

Intervention: Misoprostol 200Mcg Tab

placebo

one tablet of placebo inserted by the study nurse 3 hours before IUD insertion.

Intervention: placebo

Outcomes

Primary Outcomes

The difference in pain scores during intrauterine device insertion

Time Frame: 10 minutes

The difference in pain scores during intrauterine device insertion using visual analog scale from 0 to 10

Similar Trials